Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Altimmune (ALT) Preferred Shares Issued (2016 - 2017)

Altimmune (ALT) has disclosed Preferred Shares Issued for 2 consecutive years, with $13.0 million as the latest value for Q3 2017.

  • On a quarterly basis, Preferred Shares Issued rose 548.63% to $13.0 million in Q3 2017 year-over-year; TTM through Dec 2017 was $15.0 million, a N/A change, with the full-year FY2017 number at $13.0 million, up 129.46% from a year prior.
  • Preferred Shares Issued was $13.0 million for Q3 2017 at Altimmune, up from $2.0 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $13.0 million in Q3 2017 to a low of $2.0 million in Q3 2016.